{"paper_id":"cc50cb57-066d-4326-b73d-b6d047716e3f","body_text":"References\nDmowski WP, Braun D, Gebel H: Endometriosis: Genetic and immunologic aspects.In Current Concepts in Endometriosis. New York, Alan R. Liss, 1990, pp 99–122\nVentruba P, Crha I, Vlckova V, Vlasin Z: Anticardiolipin, antihistones and antinuclear antibodies in women with fertility disorders. Hum Reprod (Suppl 1) 1993;8:169\nHarris EN, Ghavari AE: Evaluation of the anti-cardiolipin antibody test. Clin Exp Imunol 1986;68:215\nGompertz NR, Isenberg DA: Correlation between clinical features of SLE and levels of antihiston antibodies of the IgG, IgA and IgM isotypes. Ann Rheum Dis 1990;49:524–527\nGleicher N: Autoimmunity and Reproductive Failure.In Frontiers in Human Reproduction. Ann NY Acad Sci 1991;626:537–544\nVentruba P, Muller P, Mlyncek M, Crha I: Multicentric study of Zoladex in the treatment of endometriosis—Preliminary report. Int J Gynecol Obstet (Suppl 1) 1994;46:168\nEl-Roeiy A, Dmowski WP, Gleicher N: Danazol but not gonadotropin-releasing hormone agonists supreses autoantibodies in endometriosis. Fertil Steril 1988;50:864–871\nAuthor information\nAuthors and Affiliations\nRights and permissions\nAbout this article\nCite this article\nCrha, I., Ventruba, P. Anticardiolipin and antihiston levels during the treatment of IVF patients with endometriosis by Goserelin. J Assist Reprod Genet 13, 366–368 (1996). https://doi.org/10.1007/BF02070154\nReceived:\nAccepted:\nIssue date:\nDOI: https://doi.org/10.1007/BF02070154","source_license":"CC0","license_restricted":false}